Since UDG depletion is known to sensitize cancer cells to chemotherapy,93 the ability of the identified UDG inhibitor A8 to synergize with the anticancer drug, 5-FU, was next investigated in prostate cancer cells. This evidence concerns the gene UNG and prostate carcinoma.